SCAGLIOTTI, Giorgio Vittorio
SCAGLIOTTI, Giorgio Vittorio
ONCOLOGIA
141PD: Whole body and intracranial efficacy of ceritinib in patients (pts) with crizotinib (CRZ) pretreated, ALK-rearranged (ALK+) non-small cell lung cancer (NSCLC) and baseline brain metastases (BM): Results from ASCEND-1 and ASCEND-2 trials
2016-01-01 Felip, E; Crinò, L; Kim, D-W; Spigel, D R; Nishio, M; Mok, T; Scagliotti, G; Cesic, D; Sutradhar, S; Shaw, A T
The 2021 WHO Classification of Lung Tumors: Impact of Advances Since 2015
2022-01-01 Nicholson A.G.; Tsao M.S.; Beasley M.B.; Borczuk A.C.; Brambilla E.; Cooper W.A.; Dacic S.; Jain D.; Kerr K.M.; Lantuejoul S.; Noguchi M.; Papotti M.; Rekhtman N.; Scagliotti G.; van Schil P.; Sholl L.; Yatabe Y.; Yoshida A.; Travis W.D.
A randomized phase II study comparing induction or consolidation chemotherapy with cisplatin-docetaxel, plus radical concurrent chemoradiotherapy with cisplatin-docetaxel, in patients with unresectable locally advanced non-small-cell lung cancer.
2011-01-01 Senan S; Cardenal F; Vansteenkiste J; Stigt J; Akyol F; De Neve W; Bakker J; Dupont JM; Scagliotti GV; Ricardi U; van Meerbeeck JP.
Abiraterone and prednisone therapy may cause severe hypoglycemia when administered to prostate cancer patients with type 2 diabetes receiving glucose-lowering agents
2019-01-01 Tucci M.; Roca E.; Ferrari L.; Pia A.; Dalla Volta A.; Bedussi F.; Buttigliero C.; Vittorio Scagliotti G.; Sigala S.; Berruti A.
The Accuracy of Clinical Staging of Stage I-IIIa Non-Small Cell Lung Cancer: An Analysis Based on Individual Participant Data
2019-01-01 Navani, Neal*; Fisher, David J.; Tierney, Jayne F.; Stephens, Richard J.; Burdett, Sarah; Rydzewska, Larysa H.M.; Auperin, Anne; Le Chevalier, Thierry; Le Pechoux, Cécile; Pignon, Jean-Pierre; Arriagada, Rodrigo; Johnson, David H.; van Meerbeeck, Jan; Parmar, Mahesh K.B.; Stewart, Lesley A.; Bunn, Paul A.; Dautzenberg, Bertrand; Gilligan, David; Groen, Harry; Knuuttila, Aija; Vallieres, Eric; Rosell, Rafael; Roth, Jack; Scagliotti, Giorgio; Tsuboi, Masahiro; Waller, David; Westeel, Virginie; Wu, Yi-Long; Yang, Xue-Ning
Adapting clinical practice guidelines to a regional oncology network: the Piedmont experience
2007-01-01 GELORMINO E; PAGANO E; APPIANO S; CECCARELLI M; CIUFFREDA L; COMANDONE A; FARINA E; MERLETTI F; MUSSA A; PENNA A; PONTI A; RACITI I; SCAGLIOTTI GV; SEGNAN N; SENORE C; SISMONDI P; VINEIS P; BERTETTO O; CICCONE G
Addition of docetaxel to androgen deprivation therapy for patients with hormone-sensitive metastatic prostate cancer: A systematic review and meta-analysis
2016-01-01 Tucci, Marcello; Bertaglia, Valentina; Vignani, Francesca; Buttigliero, Consuelo; Fiori, Cristian; Porpiglia, Francesco; Scagliotti, Giorgio Vittorio; Di Maio, Massimo
Addressing the unmet need in lung cancer: The potential of immuno-oncology
2015-01-01 Scagliotti, G.V; Bironzo, P.; Vansteenkiste, J.F.
Adjuvant and Neoadjuvant approaches for non small cell lung cancer
2005-01-01 Scagliotti GV; Everett E. V.
Adjuvant chemotherapy after complete resection for early stage NSCLC
2003-01-01 SCAGLIOTTI G ;NOVELLO S
Adjuvant chemotherapy for resected early-stage non-small cell lung cancer
2015-01-01 Burdett, S; Pignon, Jp; Tierney, J; Tribodet, H; Stewart, L; Le Pechoux, C; Auperin, A; Le Chevalier, T; Stephens, Rj; Arriagada, R; Higgins, Jpt; Johnson, Dh; Van Meerbeeck, J; Parmar, Mkb; Souhami, Rl; Bergman, B; Douillard, Jy; Dunant, A; Endo, C; Girling, D; Kato, H; Keller, Sm; Kimura, H; Knuuttila, A; Kodama, K; Komaki, R; Kris, Mg; Lad, T; Mineo, T; Piantadosi, S; Rosell, R; Scagliotti, G; Seymour, Lk; Shepherd, Fa; Sylvester, R; Tada, H; Tanaka, F; Torri, V; Waller, D; Liang, Y
Adjuvant chemotherapy in completely resected Non-small cel lung cancer.
2005-01-01 GIORGIO V. SCAGLIOTTI; S. NOVELLO; AND VALTER TORRI
Adjuvant chemotherapy in completely resected Non-Small Cell Lung Cancer, cap 32
2005-01-01 GIORGIO V. SCAGLIOTTI; S. NOVELLO; AND VALTER TORRI
Adjuvant therapy for surgically resected NSCLC: update from ASCO 2004. Selected presentations from the 5th international Lung Cancer , Kauai, Hi July 2004
2004-01-01 Scagliotti GV; Novello S.
Adjuvant therapy in completely resected non-small-cell lung cancer
2003-01-01 Scagliotti, G.V., Novello, S
Aflibercept and Docetaxel Versus Docetaxel Alone After Platinum Failure in Patients With Advanced or Metastatic Non-Small-Cell Lung Cancer: A Randomized, Controlled Phase III Trial.
2012-01-01 Ramlau R; Gorbunova V; Ciuleanu TE; Novello S; Ozguroglu M; Goksel T; Baldotto C; Bennouna J; Shepherd FA; Le-Guennec S; Rey A; Miller V; Thatcher N; Scagliotti G.
Alberta Breakthrough Pain Assessment Tool: A validation multicentre study in cancer patients with breakthrough pain
2015-01-01 Sperlinga, R.; Campagna, S.; Berruti, A.; Laciura, P.; Ginosa, I.; Paoletti, S.; Giuliano, P.L.; Tucci, M.; Rosato, R.; Scagliotti, G.V.; Saini, Andrea
ALK Rearrangement Testing by FISH Analysis in Non-Small-Cell Lung Cancer Patients: Results of the First Italian External Quality Assurance Scheme.
2014-01-01 Marchetti A;Barberis M;Papotti M;Rossi G;Franco R;Malatesta S;Buttitta F;Ardizzoni A;Crinò L;Gridelli C;Taddei GL;Clemente C;Scagliotti G;Normanno N;Pinto C
ALK translocation and crizotinib in non-small cell lung cancer: an evolving paradigm in oncology drug development.
2012-01-01 Scagliotti G; Stahel RA; Rosell R; Thatcher N; Soria JC.
ALTERED MRNAS EXPRESSION OF GENES INVOLVED IN CELLULAR IRON HOMEOSTASIS IN LUNG NON SMALL CELLS CARCINOMA
2012-01-01 Lo Iacono M; Roetto A; Monica V; Boero M; Vavala T; Saviozzi S; Bracco E; Novello S; Papotti M; Scagliotti GV
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| 141PD: Whole body and intracranial efficacy of ceritinib in patients (pts) with crizotinib (CRZ) pretreated, ALK-rearranged (ALK+) non-small cell lung cancer (NSCLC) and baseline brain metastases (BM): Results from ASCEND-1 and ASCEND-2 trials | 2016 | Felip, E; Crinò, L; Kim, D-W; Spigel, D R; Nishio, M; Mok, T; Scagliotti, G; Cesic, D; Sutradhar, S; Shaw, A T | |
| The 2021 WHO Classification of Lung Tumors: Impact of Advances Since 2015 | 2022 | Nicholson A.G.; Tsao M.S.; Beasley M.B.; Borczuk A.C.; Brambilla E.; Cooper W.A.; Dacic S.; Jain D.; Kerr K.M.; Lantuejoul S.; Noguchi M.; Papotti M.; Rekhtman N.; Scagliotti G.; van Schil P.; Sholl L.; Yatabe Y.; Yoshida A.; Travis W.D. | |
| A randomized phase II study comparing induction or consolidation chemotherapy with cisplatin-docetaxel, plus radical concurrent chemoradiotherapy with cisplatin-docetaxel, in patients with unresectable locally advanced non-small-cell lung cancer. | 2011 | Senan S; Cardenal F; Vansteenkiste J; Stigt J; Akyol F; De Neve W; Bakker J; Dupont JM; Scagliotti GV; Ricardi U; van Meerbeeck JP. | |
| Abiraterone and prednisone therapy may cause severe hypoglycemia when administered to prostate cancer patients with type 2 diabetes receiving glucose-lowering agents | 2019 | Tucci M.; Roca E.; Ferrari L.; Pia A.; Dalla Volta A.; Bedussi F.; Buttigliero C.; Vittorio Scagliotti G.; Sigala S.; Berruti A. | |
| The Accuracy of Clinical Staging of Stage I-IIIa Non-Small Cell Lung Cancer: An Analysis Based on Individual Participant Data | 2019 | Navani, Neal*; Fisher, David J.; Tierney, Jayne F.; Stephens, Richard J.; Burdett, Sarah; Rydzewska, Larysa H.M.; Auperin, Anne; Le Chevalier, Thierry; Le Pechoux, Cécile; Pignon, Jean-Pierre; Arriagada, Rodrigo; Johnson, David H.; van Meerbeeck, Jan; Parmar, Mahesh K.B.; Stewart, Lesley A.; Bunn, Paul A.; Dautzenberg, Bertrand; Gilligan, David; Groen, Harry; Knuuttila, Aija; Vallieres, Eric; Rosell, Rafael; Roth, Jack; Scagliotti, Giorgio; Tsuboi, Masahiro; Waller, David; Westeel, Virginie; Wu, Yi-Long; Yang, Xue-Ning | |
| Adapting clinical practice guidelines to a regional oncology network: the Piedmont experience | 2007 | GELORMINO E; PAGANO E; APPIANO S; CECCARELLI M; CIUFFREDA L; COMANDONE A; FARINA E; MERLETTI F; MUSSA A; PENNA A; PONTI A; RACITI I; SCAGLIOTTI GV; SEGNAN N; SENORE C; SISMONDI P; VINEIS P; BERTETTO O; CICCONE G | |
| Addition of docetaxel to androgen deprivation therapy for patients with hormone-sensitive metastatic prostate cancer: A systematic review and meta-analysis | 2016 | Tucci, Marcello; Bertaglia, Valentina; Vignani, Francesca; Buttigliero, Consuelo; Fiori, Cristian; Porpiglia, Francesco; Scagliotti, Giorgio Vittorio; Di Maio, Massimo | |
| Addressing the unmet need in lung cancer: The potential of immuno-oncology | 2015 | Scagliotti, G.V; Bironzo, P.; Vansteenkiste, J.F. | |
| Adjuvant and Neoadjuvant approaches for non small cell lung cancer | 2005 | Scagliotti GV; Everett E. V. | |
| Adjuvant chemotherapy after complete resection for early stage NSCLC | 2003 | SCAGLIOTTI G ;NOVELLO S | |
| Adjuvant chemotherapy for resected early-stage non-small cell lung cancer | 2015 | Burdett, S; Pignon, Jp; Tierney, J; Tribodet, H; Stewart, L; Le Pechoux, C; Auperin, A; Le Chevalier, T; Stephens, Rj; Arriagada, R; Higgins, Jpt; Johnson, Dh; Van Meerbeeck, J; Parmar, Mkb; Souhami, Rl; Bergman, B; Douillard, Jy; Dunant, A; Endo, C; Girling, D; Kato, H; Keller, Sm; Kimura, H; Knuuttila, A; Kodama, K; Komaki, R; Kris, Mg; Lad, T; Mineo, T; Piantadosi, S; Rosell, R; Scagliotti, G; Seymour, Lk; Shepherd, Fa; Sylvester, R; Tada, H; Tanaka, F; Torri, V; Waller, D; Liang, Y | |
| Adjuvant chemotherapy in completely resected Non-small cel lung cancer. | 2005 | GIORGIO V. SCAGLIOTTI; S. NOVELLO; AND VALTER TORRI | |
| Adjuvant chemotherapy in completely resected Non-Small Cell Lung Cancer, cap 32 | 2005 | GIORGIO V. SCAGLIOTTI; S. NOVELLO; AND VALTER TORRI | |
| Adjuvant therapy for surgically resected NSCLC: update from ASCO 2004. Selected presentations from the 5th international Lung Cancer , Kauai, Hi July 2004 | 2004 | Scagliotti GV; Novello S. | |
| Adjuvant therapy in completely resected non-small-cell lung cancer | 2003 | Scagliotti, G.V., Novello, S | |
| Aflibercept and Docetaxel Versus Docetaxel Alone After Platinum Failure in Patients With Advanced or Metastatic Non-Small-Cell Lung Cancer: A Randomized, Controlled Phase III Trial. | 2012 | Ramlau R; Gorbunova V; Ciuleanu TE; Novello S; Ozguroglu M; Goksel T; Baldotto C; Bennouna J; Shepherd FA; Le-Guennec S; Rey A; Miller V; Thatcher N; Scagliotti G. | |
| Alberta Breakthrough Pain Assessment Tool: A validation multicentre study in cancer patients with breakthrough pain | 2015 | Sperlinga, R.; Campagna, S.; Berruti, A.; Laciura, P.; Ginosa, I.; Paoletti, S.; Giuliano, P.L.; Tucci, M.; Rosato, R.; Scagliotti, G.V.; Saini, Andrea | |
| ALK Rearrangement Testing by FISH Analysis in Non-Small-Cell Lung Cancer Patients: Results of the First Italian External Quality Assurance Scheme. | 2014 | Marchetti A;Barberis M;Papotti M;Rossi G;Franco R;Malatesta S;Buttitta F;Ardizzoni A;Crinò L;Gridelli C;Taddei GL;Clemente C;Scagliotti G;Normanno N;Pinto C | |
| ALK translocation and crizotinib in non-small cell lung cancer: an evolving paradigm in oncology drug development. | 2012 | Scagliotti G; Stahel RA; Rosell R; Thatcher N; Soria JC. | |
| ALTERED MRNAS EXPRESSION OF GENES INVOLVED IN CELLULAR IRON HOMEOSTASIS IN LUNG NON SMALL CELLS CARCINOMA | 2012 | Lo Iacono M; Roetto A; Monica V; Boero M; Vavala T; Saviozzi S; Bracco E; Novello S; Papotti M; Scagliotti GV |